- Home
- FLNT vs VTVT Comparison
FLNT vs VTVT Comparison
Compare FLNT & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNT
- VTVT
- Stock Information
- Founded
- FLNT 2010
- VTVT 2015
- Country
- FLNT United States
- VTVT United States
- Employees
- FLNT N/A
- VTVT N/A
- Industry
- FLNT Advertising
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- FLNT Consumer Discretionary
- VTVT Health Care
- Exchange
- FLNT Nasdaq
- VTVT Nasdaq
- Market Cap
- FLNT 47.1M
- VTVT 38.8M
- IPO Year
- FLNT N/A
- VTVT 2015
- Fundamental
- Price
- FLNT $2.89
- VTVT $14.05
- Analyst Decision
- FLNT Hold
- VTVT Strong Buy
- Analyst Count
- FLNT 1
- VTVT 1
- Target Price
- FLNT $4.00
- VTVT $35.00
- AVG Volume (30 Days)
- FLNT 23.5K
- VTVT 8.5K
- Earning Date
- FLNT 02-27-2025
- VTVT 03-12-2025
- Dividend Yield
- FLNT N/A
- VTVT N/A
- EPS Growth
- FLNT N/A
- VTVT N/A
- EPS
- FLNT N/A
- VTVT N/A
- Revenue
- FLNT $261,976,999.00
- VTVT $1,000,000.00
- Revenue This Year
- FLNT N/A
- VTVT N/A
- Revenue Next Year
- FLNT $6.23
- VTVT N/A
- P/E Ratio
- FLNT N/A
- VTVT N/A
- Revenue Growth
- FLNT N/A
- VTVT 11011.11
- 52 Week Low
- FLNT $2.31
- VTVT $7.38
- 52 Week High
- FLNT $4.30
- VTVT $30.99
- Technical
- Relative Strength Index (RSI)
- FLNT 56.94
- VTVT 46.82
- Support Level
- FLNT $2.53
- VTVT $13.90
- Resistance Level
- FLNT $2.91
- VTVT $14.35
- Average True Range (ATR)
- FLNT 0.13
- VTVT 0.58
- MACD
- FLNT 0.04
- VTVT 0.03
- Stochastic Oscillator
- FLNT 86.02
- VTVT 42.61
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers they are seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.